定制的类似病毒的粒子作为医学突破的驱动力
Rafael Travassos1, Sofia A Martins1, Ana Fernandes1
1Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa, CTN, Estrada Nacional 10 (km 139.7), 2695-066 Bobadela, Portugal.
International journal of molecular sciences
|June 27, 2024
概括
病毒样颗粒 (VLP) 为医疗应用提供了比传统纳米颗粒更安全,更通用的替代方案. 表面功能化增强了它们的准,稳定性和对药物和疫苗的响应能力.
科学领域:
- 生物技术和纳米医学
- 材料科学 材料科学 材料科学
- 免疫学 免疫学 免疫学
背景情况:
- 传统的纳米颗粒在临床转化中面临挑战,因为安全性和有效性问题.
- 病毒样颗粒 (VLP) 是一个有前途的替代品,具有固有的安全性,生物相容性和结构完整性.
- VLP为先进的治疗和诊断应用提供了多功能平台.
研究的目的:
- 审查病毒样粒子 (VLP) 的各种表面功能化策略.
- 突出用于设计定制VLP的尖端技术.
- 讨论功能化VLP的医疗应用和重要性.
主要方法:
- 关于VLP表面功能化技术的文献综述.
- 通过表面修改调节的VLP属性的分析.
- 在药物输送和疫苗学中探索VLP应用.
主要成果:
- VLP的表面功能化可以改善循环半衰期和目标特异性.
- 可为刺激响应行为 (热量,pH值,磁场,酶) 设计VLP.
- 功能化的VLP显示出作为候选疫苗和复杂的输送系统的潜力.
结论:
- 表面功能化是优化医疗应用VLP性能的关键.
- 量身定制的VLP代表了纳米医学和药物输送的重大进步.
- 对于未来的治疗干预和疫苗开发,VLP具有相当大的前景.
相关概念视频
Viral Mutations
32.2K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.2K
Viral Recombination
23.4K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.4K


